Alirocumab, page-8

For anyone discounting Uncle Keith as constituting a well informed source , I would provide the following example of his credibility :
In his Oct 7 , 2014 update he also said , in-part :
“MINIMIZING CAPITAL EXPENDITURES
The next question is how Unilife will be able to meet its obligations under the expansive wearable injector contract.
Management is presently working to build a strategic relationship with Flextronics, a provider of turnkey
manufacturing and distribution services to the pharmaceutical industry. We believe Flextronics Medical will serve as
a secondary source of Unilife products. In addition, some of the production equipment, which will be built to
Unilife’s specifications, will probably be owned by its customers. This is not uncommon in the industry, since it
ensures greater sourcing flexibility and minimizes supply chain risk.”

On November 13 ,2014 Unilife made the following announcement :
“Unilife and Flextronics Enter Into Global Strategic Alliance
YORK, Pa., Nov. 13, 2014 /PRNewswire/ -- Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced the signing of a Global Strategic Alliance Agreement with Flextronics (NASDAQ: FLEX), a leading end-to-end supply chain solutions company, as its global strategic partner to further expand the production capacity and scale-up capability of Unilife's product portfolio. “

So , let’s hope his other suggestions become reality , in the same way .
Regards
Q